Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Nexium was produced by AstraZeneca and Daiichi Sankyo.

AZ 'in serious trouble' say analysts

The worst case assumes that generics hit Nexium (esomeprazole) and Seroquel (quetiapine) in 2008 and Crestor (rosuvastatin calcium) in 2009.".

Symbicort patent loss drags down AZ's share value

Nexium (esomeprazole) when it was challenged by German generics firm Ratiopharm. ... AZ's reliance on Symbicort, Nexium and Crestor (rosuvastatin) has been its Achilles' heel, as the company has suffered various late-stage pipeline failures: heart

AZ begins Far East outsourcing to slash costs

Seroquel, which racked up FY06 sales of USD 3.4bn, is AZ's second best-selling product after proton pump inhibitor Nexium (esomeprazole), which brings in USD 5.2bn in sales.

Top profits

The combined sales of AZ's five key drugs - Nexium for heartburn, Seroquel, the antipsychotic treatment, Crestor for cholesterol, Arimidex for cancer and Symbicort, the asthma inhaler - shot ahead 25 per ... Nexium is the world's fifth-biggest selling

Forging ahead

AstraZeneca, however, came under heavy selling pressure on Tuesday morning after announcing it had received notice that Indian drugs group, Ranbaxy Pharmaceuticals, has applied to produce a generic version of Nexium. ... in the patents protecting Nexium.

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
Investing in our People
As a small, boutique agency we can and do invest heavily in our team, who produce amazing results for our clients....